Skip to main content
$19.47 -$0.08 (-0.4%)

04:00 PM EDT on 05/18/22

Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 3 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Current Price $19.47 Mkt Cap $2.1B
Open $19.12 P/E Ratio 19.66
Prev. Close $19.47 Div. (Yield) $0.00 (0.0%)
Daily Range $19.12 - $19.55 Volume 837,388
52-Wk Range $15.83 - $25.68 Avg. Daily Vol. 1,020,983

Caps

How do you think NASDAQ:CORT will perform against the market?

Add Stock to CAPS Watchlist

All Players

91 Outperform
26 Underperform
 

All-Star Players

15 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CORT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

vistacarolina (21.81)
Submitted March 31, 2017

Great Co. will see positive results.

zzlangerhans (99.81)
Submitted July 13, 2016

In medicine we generalists have a saying: When you only tool is a hammer, every problem becomes a nail. It refers to the propensity of specialists to interpret every problem through the lens of their specialty. If a patient comes in with syncope, the… More

Recent Community Commentary

Read the most recent pitches from players about CORT.

Recs

0
Member Avatar TMFjimhalley (28.90) Submitted: 4/20/2022 7:40:11 AM : Outperform Start Price: $23.06 NASDAQ:CORT Score: -3.35

Small-cap that is already profitable has a growing pipeline.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 6/1/2020 3:03:21 PM : Outperform Start Price: $15.27 NASDAQ:CORT Score: -0.89

already profitable, good pipeline and rapidly growing revenues

Recs

0
Member Avatar jed71 (99.16) Submitted: 2/19/2020 8:57:54 AM : Outperform Start Price: $13.25 NASDAQ:CORT Score: +30.81

It's extremely hard to deny that Corcept has delivered on financial results quarter after quarter for several years. Their gross margins are incredible and I continue to marvel at the fact that the stock remains a good value in this market. They have boatloads of cash on the sidelines and quite a few up and coming phase trials this year that should yields some exciting results. I have never been the best at selecting pharmas, but this one appears to be a good stub to put a marker on in Caps. I haven't bought yet, but am looking forward to listening to their conference call tomorrow prior to making any real life decisions.

Leaderboard

Find the members with the highest scoring picks in CORT.

Score Leader

thiscoloradokid

thiscoloradokid (< 20) Score: +1,003.42

The Score Leader is the player with the highest score across all their picks in CORT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
thiscoloradokid < 20 12/5/2012 12/4/2013 Outperform 3M $1.52 +1,180.92% +177.51% +1,003.42 0 Comment
alvojiggy 72.92 10/23/2013 Outperform 5Y $1.73 +1,025.43% +124.42% +901.01 0 Comment
GOGCwatch07 79.60 9/18/2013 Outperform 5Y $1.73 +1,025.43% +129.41% +896.03 0 Comment
FinanceGuy58 51.82 12/9/2013 7/24/2015 Outperform 3Y $2.01 +871.07% +116.43% +754.64 0 Comment
wgrohman < 20 3/21/2013 Outperform 3Y $1.94 +903.61% +153.50% +750.11 0 Comment
HoosierDoozer < 20 12/5/2013 Outperform 5Y $2.06 +845.15% +118.67% +726.48 0 Comment
loangolfer < 20 1/10/2013 11/14/2019 Outperform NS $1.96 +892.86% +167.53% +725.33 0 Comment
HoldThatWinner 28.30 3/11/2013 Outperform 1Y $2.00 +873.50% +152.57% +720.93 0 Comment
cavemantrader 44.90 11/29/2013 Outperform 5Y $2.10 +827.14% +116.36% +710.78 1 Comment
rserafini 65.46 3/25/2013 Outperform 5Y $2.04 +854.41% +151.46% +702.95 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CORT.